SG11201907935XA - 2,6-disubstituted pyridine derivative - Google Patents
2,6-disubstituted pyridine derivativeInfo
- Publication number
- SG11201907935XA SG11201907935XA SG11201907935XA SG11201907935XA SG11201907935XA SG 11201907935X A SG11201907935X A SG 11201907935XA SG 11201907935X A SG11201907935X A SG 11201907935XA SG 11201907935X A SG11201907935X A SG 11201907935XA SG 11201907935X A SG11201907935X A SG 11201907935XA
- Authority
- SG
- Singapore
- Prior art keywords
- substituted
- optionally
- alkyl
- same
- pyridine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017046904 | 2017-03-13 | ||
| PCT/JP2018/009418 WO2018168738A1 (ja) | 2017-03-13 | 2018-03-12 | ２，６－ジ置換ピリジン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201907935XA true SG11201907935XA (en) | 2019-09-27 |
Family
ID=63522157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201907935XA SG11201907935XA (en) | 2017-03-13 | 2018-03-12 | 2,6-disubstituted pyridine derivative |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11014905B2 (de) |
| EP (1) | EP3608314A4 (de) |
| JP (2) | JP6612483B2 (de) |
| KR (1) | KR20190129080A (de) |
| CN (1) | CN110382478A (de) |
| AU (1) | AU2018234001B2 (de) |
| CA (1) | CA3054782A1 (de) |
| RU (1) | RU2019132041A (de) |
| SG (1) | SG11201907935XA (de) |
| TW (1) | TW201837034A (de) |
| WO (1) | WO2018168738A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110382478A (zh) | 2017-03-13 | 2019-10-25 | 大日本住友制药株式会社 | 2,6-二取代的吡啶衍生物 |
| JP7382188B2 (ja) * | 2018-09-19 | 2023-11-16 | 住友ファーマ株式会社 | ２，６－ジ置換ピリジン誘導体からなる医薬 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5929665A (ja) | 1982-08-11 | 1984-02-16 | Sumitomo Chem Co Ltd | ピペラジン誘導体及びその酸付加塩 |
| CA1305148C (en) * | 1987-08-19 | 1992-07-14 | Hiromu Matsumura | Carbamoylpyrrolidone derivatives and drugs for senile dementia |
| JPH075546B2 (ja) * | 1987-08-19 | 1995-01-25 | 塩野義製薬株式会社 | カルバモイルピロリドン誘導体 |
| CA2100641A1 (en) | 1992-07-23 | 1994-01-24 | Hiromu Matsumura | Novel piperidine derivatives and process for preparation thereof |
| JP4866610B2 (ja) * | 2003-08-18 | 2012-02-01 | 富士フイルムファインケミカルズ株式会社 | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類 |
| EP1836192A2 (de) * | 2005-01-03 | 2007-09-26 | Universita' Degli Studi di Siena | Arylpiperazin-derivate zur behandlung neuropsychiatrischer erkrankungen |
| JP2009249346A (ja) * | 2008-04-08 | 2009-10-29 | Fujifilm Corp | ピリジン骨格を有する血液脳関門透過性化合物 |
| EP2571353B1 (de) | 2010-05-21 | 2017-08-09 | AbbVie Inc. | 5-ht-rezeptor-modulatoren und verfahren zu ihrer verwendung |
| WO2011150183A1 (en) * | 2010-05-28 | 2011-12-01 | Ge Healthcare Limited | Radiolabeled compounds and methods thereof |
| JP5929665B2 (ja) | 2012-09-24 | 2016-06-08 | 富士通株式会社 | 電解コンデンサとその製造方法 |
| JP2014192868A (ja) | 2013-03-28 | 2014-10-06 | Fujitsu Ltd | 端末装置、消費電力抑制方法及び消費電力抑制プログラム |
| JP6370294B2 (ja) | 2013-05-30 | 2018-08-08 | 大日本住友製薬株式会社 | 環状アミノメチルピリミジン誘導体 |
| CN110382478A (zh) | 2017-03-13 | 2019-10-25 | 大日本住友制药株式会社 | 2,6-二取代的吡啶衍生物 |
-
2018
- 2018-03-12 CN CN201880017909.4A patent/CN110382478A/zh active Pending
- 2018-03-12 TW TW107108257A patent/TW201837034A/zh unknown
- 2018-03-12 EP EP18767940.2A patent/EP3608314A4/de not_active Withdrawn
- 2018-03-12 US US16/487,936 patent/US11014905B2/en active Active
- 2018-03-12 AU AU2018234001A patent/AU2018234001B2/en not_active Ceased
- 2018-03-12 KR KR1020197029933A patent/KR20190129080A/ko unknown
- 2018-03-12 WO PCT/JP2018/009418 patent/WO2018168738A1/ja unknown
- 2018-03-12 RU RU2019132041A patent/RU2019132041A/ru unknown
- 2018-03-12 CA CA3054782A patent/CA3054782A1/en active Pending
- 2018-03-12 SG SG11201907935XA patent/SG11201907935XA/en unknown
- 2018-03-12 JP JP2019505994A patent/JP6612483B2/ja active Active
-
2019
- 2019-10-29 JP JP2019196160A patent/JP7097342B2/ja active Active
-
2020
- 2020-03-24 US US16/827,981 patent/US10800755B2/en active Active
-
2021
- 2021-04-23 US US17/238,691 patent/US11780820B2/en active Active
-
2023
- 2023-08-30 US US18/240,012 patent/US20230399308A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200039952A1 (en) | 2020-02-06 |
| US11014905B2 (en) | 2021-05-25 |
| RU2019132041A (ru) | 2021-04-14 |
| RU2019132041A3 (de) | 2021-07-05 |
| US11780820B2 (en) | 2023-10-10 |
| JP7097342B2 (ja) | 2022-07-07 |
| AU2018234001B2 (en) | 2022-01-06 |
| US10800755B2 (en) | 2020-10-13 |
| WO2018168738A8 (ja) | 2019-07-25 |
| KR20190129080A (ko) | 2019-11-19 |
| WO2018168738A1 (ja) | 2018-09-20 |
| EP3608314A4 (de) | 2020-12-30 |
| JP6612483B2 (ja) | 2019-11-27 |
| CN110382478A (zh) | 2019-10-25 |
| CA3054782A1 (en) | 2018-09-20 |
| US20200239432A1 (en) | 2020-07-30 |
| US20230399308A1 (en) | 2023-12-14 |
| AU2018234001A1 (en) | 2019-09-19 |
| JP2020023570A (ja) | 2020-02-13 |
| TW201837034A (zh) | 2018-10-16 |
| JPWO2018168738A1 (ja) | 2019-11-21 |
| EP3608314A1 (de) | 2020-02-12 |
| US20210332025A1 (en) | 2021-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500485A1 (en) | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors | |
| MX2018000396A (es) | Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4). | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| PE20161475A1 (es) | Pirazolopiridinas y pirazolopirimidinas | |
| MX2017010477A (es) | Compuestos triciclicos y usos de los mismos en medicina. | |
| MD4800C1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| EA201890469A1 (ru) | Соли ингибитора lsd1 | |
| PH12019500480A1 (en) | Pyridine compound | |
| WO2015095811A8 (en) | Combination therapy with neoantigen vaccine | |
| BR112015012693A2 (pt) | derivados de pirimidona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| EA201591745A1 (ru) | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантого idh | |
| BR112015018509A2 (pt) | compostos de imidazo piridina | |
| MX2015012741A (es) | Palbociclib deuterado. | |
| NZ748769A (en) | Nitroxyl donors with improved therapeutic index | |
| PH12018501443A1 (en) | Methods of administering hepcidin | |
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| SA519401322B1 (ar) | مركبات أريل كربوكساميد غير متجانسة كمثطبات لكيناز بروتين سيرين/ ثريونين متداخل مع المستقبل 2 | |
| BR112012031340A2 (pt) | derivados de cianoquinolina | |
| MX2016016491A (es) | Derivados de o-alquil-bencilidenguanidina y uso terapeutico para el tratamiento de trastornos asociados con acumulacion de proteinas mal plegadas. | |
| MX2016004963A (es) | Sal y formas cristalinas de inhibidores de quinasa tipo polo-4. | |
| SG11201907935XA (en) | 2,6-disubstituted pyridine derivative | |
| WO2015155680A3 (en) | Pyrazole derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors | |
| BR112015013414A2 (pt) | derivados de naftiridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| RU2016133022A (ru) | Средство для профилактики и/или терапии ретинального воспаления |